Mymd Pharmaceuticals, Inc.

MYMDCIK 0001321834 · Every Form 4 filed by insiders at this issuer. See financials →

Annual report (10-K)

Latest 10-K/A filed Apr 29, 2026. Sentiment + YoY language diff vs prior year. Read sections →

Signal:NeutralFull-doc fallback

Full filing:tone -0.0034

Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.

Recent 8-K announcements

Per-item disclosure feed. Item 2.02 is the earnings release.

Mar 13, 2026no items parsed Jan 23, 2026no items parsed Dec 9, 2025no items parsed Nov 14, 2025no items parsed Oct 6, 2025no items parsed

YoY shift: Unscored

Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.

Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.

Per-snippet highlights

Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.

Top insiders

Most active reporters at Mymd Pharmaceuticals, Inc.

Name	Roles	Filings
Rivard Paul	Officer	3
Voss Chelsea Sierra	Director	3
Bernstein Bruce	Director	2
Chapman Christopher C Jr	OfficerDirector	2
Eagle Craig	Director	1

Showing 6-10 of 15

Per pagePrevPage 2 of 3Next

All filings

34 Form 4 / 4-A filings, newest first

Filed	Insider	Top transaction	Shares	Price	Value
Apr 15, 2026	Voss Chelsea Sierra Director	Holdings only	-	-	-
Apr 15, 2026	White Billy Joe Director	Holdings only	-	-	-
Jan 30, 2026	Voss Chelsea Sierra Director	AGrant	212,500	$0.00	$0
Nov 18, 2025	Pharmacyte Biotech, Inc. 10% Owner	Holdings only	-	-	-
Nov 17, 2025	White Billy Joe Director	AGrant	22,839	$0.00	$0

Showing 6-10 of 34

Per pagePrevPage 2 of 7Next

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value